“Doctor, will my face ever go back to the way it was before?" The question sounds simple, but for many people living with Systemic Sclerosis, it carries an ocean of fear, uncertainty, and silent ...

Today at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived ...

In patients with systemic sclerosis, JAK inhibitors show comparable effectiveness to standard immunosuppressants, but many stop therapy due to treatment failure or adverse events.

New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell ...

Prescribing practices for immunosuppressive therapy in limited cutaneous systemic sclerosis vary among rheumatologists, especially when managing skin or subclinical organ involvement.

Systemic sclerosis (SSc), also referred to as scleroderma, is a rare autoimmune disease associated with vasculopathy, inflammation, and fibrosis of the skin and/or internal organs. Interstitial lung ...

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and ...

Systemic sclerosis (SSc) is a rare autoimmune disease that can harden the skin, impair blood flow, and damage internal organs such as the lungs and kidneys. But no two patients experience the disease ...

A new study published in the journal of Rheumatology showed that compared to healthy persons, patients with systemic ...

A guitarist who once found chart success is now using music as a source of "therapeutic resilience" while living with a rare ...

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that Black people living with systemic sclerosis may have more severe disease and ...